Defining the Role of Cholecystokinin in the Lipid-Induced Human Brain Activation Matrix
Background & Aims
In human beings, as in most vertebrates, the release of the intestinal peptide cholecystokinin (CCK) by ingested food plays a major role both in digestion and the regulation of further food intake, but the changes in brain function and their underlying activation mechanisms remain unknown. Our aim was to explore, using a novel physiologic magnetic resonance imaging approach, the temporospatial brain activation matrix, in response to ingestion of a lipid meal and, by use of a CCK-1 receptor antagonist, to define the role of CCK in this activation.
Methods
We studied, in 19 healthy subjects, the brain activation responses to ingested lipid (dodecanoic acid) or saline (control) with magnetic resonance imaging. Gallbladder volume, plasma CCK levels, and subjective hunger and fullness scores were also recorded. The experiment was then repeated, with and without prior administration of the CCK-1 receptor antagonist dexloxiglumide (600 mg orally) with a controlled, randomized order, latin-square design.
Results
Ingested lipid activated bilaterally a matrix of brain areas, particularly the brain stem, pons, hypothalamus, and also cerebellum and motor cortical areas. These activations were abolished by dexloxiglumide, indicating a CCK-mediated pathway, independent of any nutrient-associated awareness cues.
Conclusion
The identification of these activations now defines the lipid-activated brain matrix and provides a means by which the gut-derived homeostatic mechanisms of food regulation can be distinguished from secondary sensory and hedonic cues, thereby providing a new approach to exploring aberrant human gastrointestinal responses and eating behavior.
Keywords: Fatty Acid, Dexloxiglumide, Pharmacologic Magnetic Resonance Imaging, phMRI
Abbreviations used in this paper: ANOVA, analysis of variance, BMI, body mass index, C12, dodecanoic acid, CCK, cholecystokinin, CNS, central nervous system, MRI, magnetic resonance imaging.
To access this article, please choose from the options below
Conflicts of interest Massimo D'Amato is an employee of Rotta Research Laboratorium/Rottapharm, Monza, Italy. The other authors disclose no conflicts.
Funding This work was supported by grants from The Biotechnology and Biological Sciences Research Council, Translational Imaging Unit, University of Manchester, and The Mason Medical Research Foundation. The Manchester group is supported by Manchester Academic Health Sciences Centre (MAHSC).
A part of this work was first presented as an abstract at the Digestive Diseases Week, American Gastroenterology Society, Washington DC, 2007.
PII: S0016-5085(10)00024-7
doi:10.1053/j.gastro.2009.12.060
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

